Search
for
Sort by
Research 391–420 of 1000+
- Beyond the Follicle: A Narrative Review on How Systemic Diseases and Drugs Affect Alopecia
- Myristoleic Acid Promotes Anagen Signaling by Autophagy through Activating Wnt/β-Catenin and ERK Pathways in Dermal Papilla Cells
- Identification of N6-Methyladenosine-Related Factors and the Prediction of the Regulatory Mechanism of Hair Follicle Development in Rex and Hycole Rabbits
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES
- Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.
- Reply to: a rare case of vulvar skin metastasis of rectal cancer after operation
- Doxetaxel: new indication. Prostate cancer: a few more weeks.
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Editorial: Androgen-dependent diseases and their treatment
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Efeitos da finasterida sobre culturas de células epiteliais prostáticas normais e tumorais em diferentes sistemas in vitro
- 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- 411 THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER
- Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer
- Prostate cancer update: 2007
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use
- Provenge is Talk of GU Malignancies Congress
- 5α‐Reductase Inhibitors
- Prostatakarzinom
- Hormone Blocking Anticancer Drugs
- Heavy metals in biological samples of cancer patients: a systematic literature review
- Molecular mechanisms of androgen receptor functions
- Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article
- Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice
- CPC12 Coinheritance of <i>BRCA2</i> and <i>CYLD</i> germline pathogenic variants associated with targetable metastatic malignant cylindroma
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?